期刊文献+
共找到5,827篇文章
< 1 2 250 >
每页显示 20 50 100
Resilience-Oriented Approach to the Control of Ventricular Assist Devices
1
作者 Jônatas Cerqueira Dias Jeferson Cerqueira Dias +1 位作者 Milena Victoria de Azevedo Souza Diolino José dos Santos Filho 《Journal of Biomedical Science and Engineering》 2024年第8期137-156,共20页
Context: Advanced heart failure (AHF) poses a global challenge, where heart transplantation is a treatment option but limited by donor scarcity. Proposal: This study aims to enhance the performance of ventricular assi... Context: Advanced heart failure (AHF) poses a global challenge, where heart transplantation is a treatment option but limited by donor scarcity. Proposal: This study aims to enhance the performance of ventricular assist devices (VADs) in the face of adverse events (AEs) using a resilience-based approach. The objective is to develop a method for integrating resilience attributes into VAD control systems, employing dynamic risk analysis and control strategies. Results: The outcomes include a resilient control architecture enabling anticipatory, regenerative, and degenerative actions in response to AEs. A method of applied resilience (MAR) based on dynamic risk management and resilience attribute analysis was proposed. Conclusion: Dynamic integration between medical and technical teams allows continuous adaptation of control systems to meet patient needs over time, improving reliability, safety, and effectiveness of VADs, with potential positive impact on the health of heart failure patients. 展开更多
关键词 heart Failure ventricular Assist Devices RESILIENCE Dynamic Control
下载PDF
Isolated Ventricular Septal Defect: Ultrasound, Therapeutic and Evolutionary Aspects of 85 Cases in the Cardiology Department of the Ignace Deen National Hospital in Conakry
2
作者 Mamadou Bassirou Bah Amadou Diouldé Doumbouya +12 位作者 Elhdj Yaya Balde Mamadou Aliou Balde Alpha Kone Ibrahima Sory Sylla Mamadou Dian Bah Aboulaye Bah Mamadou Diallo Thierno Siradjo Balde Abdoulaye Camara Morlaye Soumaoro Ibrahima Sory Barry Souleymane Diakité Mamadou Dadhi Balde 《World Journal of Cardiovascular Diseases》 CAS 2024年第8期465-479,共15页
Introduction: Ventricular septal defect (VSD) is the most common congenital heart disease of all congenital heart defects. The aim of this study was to investigate the echographic, therapeutic and evolutionary aspects... Introduction: Ventricular septal defect (VSD) is the most common congenital heart disease of all congenital heart defects. The aim of this study was to investigate the echographic, therapeutic and evolutionary aspects of ventricular septal defects (VSD) in the general cardiology department of the Hôpital National Ignace Deen. Methods: A retrospective data collection was carried out from January 2018 to December 2023 including 85 cases of isolated IVC was performed. The variables studied were epidemiological, clinical, paraclinical, therapeutic and evolutionary. Results: Of the 320 patients seen during the study period for congenital heart disease, 85 (26.556%) were isolated IVCs. Age at diagnosis ranged from 3 months to 16 years, with an average age of 3.59 years. The most represented ethnic group was the Fulani (50.58%). The 8.24% came from consanguineous marriage versus 22.35%. 91.76% of children had a history of bronchitis. The most common clinical signs found were systolic murmur (90.58%), growth retardation (51.76%). Only 4 cases (4.70%) had a malformation associated with IVC represented by DiGeorges disease (2.35%) and trisomy 21 (2.35%). Nearly half the patients had type IIb VIC (44.71%). The other half were represented by type 1 (18.82%), type IIa (20%), type III (10.59%) and type IV (5.88%). According to site more than two-thirds of VICs (71.64%) were perimembranous in location, followed by infundibular (16.47%) and muscular (11.76%) VICs. In our study 55.29% presented an indication for both surgical intervention and medical treatment, while 16.47% required only medical treatment. In contrast, 28.23% were placed under exclusive surveillance. Of the 47 patients for whom surgery was indicated, 29 (61.17%) underwent surgical repair, while 18 (38.83%) were awaiting confirmation for surgery. Conclusion: VIC is the most common congenital heart disease. An early detection strategy and the establishment of specialized centers could improve the outcome of these children. 展开更多
关键词 ventricular Septal Defect Congenital heart Disease Ignace Deen
下载PDF
I-123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients 被引量:2
3
作者 Weihua Zhou Ji Chen 《The Journal of Biomedical Research》 CAS 2013年第6期460-466,共7页
Compared to antiarrhythmic drugs, implantable cardioverter defibrillator (ICD) leads to a more significant im- provement in preventing ventricular arrhythmia in heart failure patients. However, an important question... Compared to antiarrhythmic drugs, implantable cardioverter defibrillator (ICD) leads to a more significant im- provement in preventing ventricular arrhythmia in heart failure patients. However, an important question has been raised that how to select appropriate patients for ICD therapy. 1-123 metaiodobenzylguanidine (MIBG) planar and SPECT imaging have shown great potentials to predict ventricular arrhythmia in heart failure patients by as- sessing the abnormalities of the sympathetic nervous system. Clinical trials demonstrated that several parameters measured from 1-123 MIBG planar and SPECT imaging, such as heart-to-mediastinum ratio, washout rate, defect score, and innervation/perfusion mismatch, predicted ventricular arrhythmias in heart failure patients. This paper introduces the current practice of ICD therapy and reviews the technical background of 1-123 MIBG planar and SPECT imaging and their clinical data in predicting ventricular arrhythmia. 展开更多
关键词 heart failure ventricular arrhythmia implantable cardioverter defibrillator 1-123 metaiodobenzyl- guanidine (MIBG)
下载PDF
Diagnosis and treatment of heart failure with preserved left ventricular ejection fraction 被引量:12
4
作者 Robert J Henning 《World Journal of Cardiology》 CAS 2020年第1期7-25,共19页
Nearly six million people in United States have heart failure.Fifty percent of these people have normal left ventricular(LV)systolic heart function but abnormal diastolic function due to increased LV myocardial stiffn... Nearly six million people in United States have heart failure.Fifty percent of these people have normal left ventricular(LV)systolic heart function but abnormal diastolic function due to increased LV myocardial stiffness.Most commonly,these patients are elderly women with hypertension,ischemic heart disease,atrial fibrillation,obesity,diabetes mellitus,renal disease,or obstructive lung disease.The annual mortality rate of these patients is 8%-12%per year.The diagnosis is based on the history,physical examination,laboratory data,echocardiography,and,when necessary,by cardiac catheterization.Patients with obesity,hypertension,atrial fibrillation,and volume overload require weight reduction,an exercise program,aggressive control of blood pressure and heart rate,and diuretics.Miniature devices inserted into patients for pulmonary artery pressure monitoring provide early warning of increased pulmonary pressure and congestion.If significant coronary heart disease is present,coronary revascularization should be considered. 展开更多
关键词 Diastolic heart failure Myocardial stiffness Incomplete left ventricular relaxation Echocardiographic heart failure criteria Pulmonary artery pressure monitoring Drug treatment
下载PDF
Left ventricular assist devices as destination therapy in stage D heart failure 被引量:1
5
作者 Rabea Asleh Sarah S.Schettle +1 位作者 Fazal W.Khan Sudhir S.Kushwaha 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2019年第8期592-600,共9页
1 Introduction? Mechanical circulatory support (MCS) has increasingly become an important management opportunity for patients with stage D heart failure (HF) with remarkable impact on patient survival and quality of l... 1 Introduction? Mechanical circulatory support (MCS) has increasingly become an important management opportunity for patients with stage D heart failure (HF) with remarkable impact on patient survival and quality of life. Early clinical trials have demonstrated improved outcomes of durable left ventricular assist device (LVAD) support compared with optimal medical management.[1] As technology advanced, continuous flow LVADs outperformed pulsatile flow devices in clinical trials and the field migrated to HeartMate (Abbott Laboratories, Abbott Park, IL) and HeartWare (Medtronic, Minneapolis, MN) devices due to their clinical superiority. Among the continuous flow devices. 展开更多
关键词 heart failure LEFT ventricular assist devices OUTCOME Patient selection The ELDERLY
下载PDF
Polymorphic ventricular tachycardia during phase Ⅱ cardiac rehabilitation in a patient with heart failure: a case report
6
作者 Hee-Eun Choi Chul Kim +5 位作者 Se-Heum Park Doo-Il Kim Ki-Hun Kim Dong-Kie Kim Seunghwan Kim Jino Park 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2020年第1期64-66,共3页
A 67-year-old man with a history of a prior cardiac arrest with ventricular fibrillation(VF)due to myocardial infarction underwent phase I(inpatient)and II(outpatient)cardiac rehabilitation(CR)exercise training.On the... A 67-year-old man with a history of a prior cardiac arrest with ventricular fibrillation(VF)due to myocardial infarction underwent phase I(inpatient)and II(outpatient)cardiac rehabilitation(CR)exercise training.On the 33th CR session,15 min after the start of exercise training,the patient had syncope with evidence of a polymorphic and wide QRS complex tachycardia on electrocardiogram(ECG)monitoring.The initiation of a polymorphic ventricular tachycardia was evidenced by the coupled premature ventricular complex observed in the ECG monitoring screen(Figure 1). 展开更多
关键词 Cardiac rehabilitation heart failure ventricular tachycardia
下载PDF
Real-time Three-dimensional Echocardiographic Assessment of Left Ventricular Remodeling Index in Patients with Hypertensive Heart Disease and Coronary Artery Disease 被引量:15
7
作者 陈明 王静 +5 位作者 谢明星 王新房 吕清 王蕾 李燕 付曼丽 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2009年第1期122-126,共5页
Left ventricular remodeling index (LVRI) was assessed in patients with hypertensive heart disease (HHD) and coronary artery disease (CAD) by real-time three-dimensional echocardiography (RT3DE). RT3DE data of ... Left ventricular remodeling index (LVRI) was assessed in patients with hypertensive heart disease (HHD) and coronary artery disease (CAD) by real-time three-dimensional echocardiography (RT3DE). RT3DE data of 18 patients with HHD, 20 patients with CAD and 22 normal controis (NC) were acquired. Left ventricular end-diastolic volume (EDV) and left ventricular end-diastolic epicardial volume (EDVepi) were detected by RT3DE and two-dimensional echocardiography Simpson biplane method (2DE). LVRI (left ventricular mass/EDV) was calculated and compared. The results showed that LVRI measurements detected by RT3DE and 2DE showed significant differences inter-groups (P〈0.01). There was no significant difference in NC group (P〉0.05), but significant difference in HHD and CAD intra-group (P〈0.05). There was good positive correlations between LVRI detected by RT3DE and 2DE in NC and HHD groups (t=0.69, P〈0.01; r=0.68, P〈0.01), but no significant correlation in CAD group (r=0.30, P〉0.05). It was concluded that LVRI derived from RT3DE as a new index for evaluating left ventricular remodeling can provide more superiority to LVRI derived from 2DE. 展开更多
关键词 echocardiography real-time three-dimensional left ventricular remodeling index hypertensive heart disease coronary artery disease
下载PDF
MRI-guided ablation of wide complex tachycardia in a univentricular heart
8
作者 Theresa Reiter Oliver Ritter +2 位作者 Peter Nordbeck Meinrad Beer Wolfgang Rudolf Bauer 《World Journal of Cardiology》 CAS 2012年第8期260-263,共4页
Magnetic resonance imaging can be used for preprocedural assessment of complex anatomy for radiofrequency(RF) ablations,e.g.,in a univentricular heart.This case report features the treatment of a young patient with a ... Magnetic resonance imaging can be used for preprocedural assessment of complex anatomy for radiofrequency(RF) ablations,e.g.,in a univentricular heart.This case report features the treatment of a young patient with a functionally univentricular heart who suffered from persistent sudden onset tachycardia with wide complexes that required RF ablation as treatment. 展开更多
关键词 MAGNETIC RESONANCE imaging Ablation Univentricular heart Fontan’s Operation ventricular TACHYCARDIA
下载PDF
Impact of Ventricular Assist Device Implantation on Clinical and Economic Outcomes of Heart Transplantation in the United States from 2003-2007
9
作者 Julie W. Doberne Brian Diggs +5 位作者 Frederick Tibayan Matthew Slater Christopher V. Chien Jill Gelow James Mudd Howard K. Song 《World Journal of Cardiovascular Surgery》 2013年第5期154-159,共6页
The use of ventricular assist devices (VADs) as a bridge to transplantation (BTT) has evolved considerably as clinical experience has grown and newer generation devices have become available. This study investigated t... The use of ventricular assist devices (VADs) as a bridge to transplantation (BTT) has evolved considerably as clinical experience has grown and newer generation devices have become available. This study investigated the impact of VAD implantation on the clinical and economic outcomes of patients undergoing heart transplantation in the United States(US) from 2003-2007. A retrospective study was carried out using the Nationwide Inpatient Sample, to track the characteristics and outcomes of an estimated 7859 patients undergoing heart transplantation in the United States from 2003-2007. Patients were divided based on whether they were bridged to transplant with a VAD and whether they were outpatient (VAD Outpt) or inpatient (VAD Inpt). Multivariate analysis was performed to identify risk factors for inhospital mortality following heart transplantation. Hospital costs were also measured. A VAD was used as a BTT in 20.8% of patients undergoing heart transplantation during the study period. Early in the series the frequency of VAD Outpts and Inpts was similar but in later years patients were more commonly bridged as outpatients. Hospital mortality for the entire population was 6.2%. Multivariate analysis identified several risk factors for mortality, including advanced age, history of congenital heart disease, and VAD Inpt status. VAD Inpt status was the strongest predictor of mortality. The hospital cost of patients bridged as inpatients was more than double the cost of outpatients. Median hospital cost declined by 11% over the study period, from $115,868 to $103,578. Much of this cost reduction was related to the shift in VAD status from Inpt to Outpt. Heart transplant recipients are increasingly bridged to transplantation with VADs as outpatients. Those bridged as inpatients have substantially higher hospital mortality and cost. These findings have important clinical implications and should inform policy development, resource utilization and donor allocation. 展开更多
关键词 ventricular Assist Device heart TRANSPLANTATION Cost EFFECTIVENESS
下载PDF
Electrophysiological changes of autonomic cells in left ventricular outflow tract in guinea pigs with iron deficiency anemia complicated with chronic heart failure 被引量:4
10
作者 Ling Fan Li-Feng Chen Jing Fan 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2017年第12期1197-1200,共4页
Objective: To investigate the electrophysiological changes of autonomic cells in left ventricular outflow tract in guinea pigs with iron deficiency anemia complicated with chronic heart failure.Methods: Guinea pigs mo... Objective: To investigate the electrophysiological changes of autonomic cells in left ventricular outflow tract in guinea pigs with iron deficiency anemia complicated with chronic heart failure.Methods: Guinea pigs model of iron deficiency anemia complicated with chronic heart failure in 10 guinea pigs of the experimental group was made by feeding a low iron diet,pure water and subcutaneous injection of isoproterenol. The control group consisting of 11 guinea pigs was given normal food, normal water and injected with normal saline. The left ventricular outflow tract model specimen was also prepared. The standard microelectrode technique was used to observe electrophysiological changes of autonomic cells in the outflow tract of left ventricular heart failure complicated with iron deficiency anemia in guinea pig model. The indicators of observation were maximal diastolic potential, action potential amplitude, 0 phase maximal depolarization velocity, 4 phase automatic depolarization velocity, repolarization 50% and 90%, and spontaneous discharge frequency.Results: Compared with the control group, 4 phase automatic depolarization velocity,spontaneous discharge frequency and 0 phase maximal depolarization velocity decreased significantly(P < 0.01) and action potential amplitude reduced(P < 0.01) in model group. Moreover, repolarization 50% and 90% increased(P < 0.01).Conclusions: There are electrophysiological abnormalities of the left ventricular outflow tract in guinea pigs with iron deficiency anemia complicated with heart failure. 展开更多
关键词 Iron deficiency anemia Chronic heart failure Guinea pig model Autonomic cells Left ventricular outflow tract ELECTROPHYSIOLOGY
下载PDF
A Case Report of Isolated Left Ventricular Non-Compaction Presenting with Congestive Heart Failure and Intramural Thrombus
11
作者 Laxmi Narayan Goit Shaning Yang 《Yangtze Medicine》 2019年第1期64-71,共8页
Isolated left ventricular non-compaction is recently described as a rare form of cardiomyopathy that is associated with a heart failure, life threatening cardiac arrhythmia and thromboembolic complications. The diagno... Isolated left ventricular non-compaction is recently described as a rare form of cardiomyopathy that is associated with a heart failure, life threatening cardiac arrhythmia and thromboembolic complications. The diagnosis is based on echocardiography demonstration of spongy myocardium. Here we report a case of 74 years old female patient diagnosed as an isolated left ventricular non-compaction with congestive heart failure, intramural thrombus and hypertension. There is no specific treatment for LVNC;therapeutic measures are directed towards the patient’s symptom (heart failure, arrhythmia and thrombotic events) and consideration of an implantable cardioverter defibrillator and cardiac transplantation. 展开更多
关键词 Left ventricular NON-COMPACTION CARDIOMYOPATHY heart Failure ARRHYTHMIA heart Transplantation
下载PDF
压力-应变环评价心脏淀粉样变左心室心肌做功的价值
12
作者 张音佳 金佳美 +4 位作者 邢雨蒙 王海尔 王燕 钟春燕 陈林 《中国临床医学影像杂志》 CAS CSCD 北大核心 2024年第6期418-422,433,共6页
目的:探讨压力-应变环评价不同左心室射血分数(Left ventricular ejection fraction,LVEF)的心脏淀粉样变(Cardiac amyloidosis,CA)患者左心室心肌做功的价值。方法:回顾性分析23例CA患者(CA1组16例,LVEF≥50%;CA2组7例,LVEF<50%)和2... 目的:探讨压力-应变环评价不同左心室射血分数(Left ventricular ejection fraction,LVEF)的心脏淀粉样变(Cardiac amyloidosis,CA)患者左心室心肌做功的价值。方法:回顾性分析23例CA患者(CA1组16例,LVEF≥50%;CA2组7例,LVEF<50%)和25例健康受试者(对照组)基于二维斑点追踪技术的压力-应变环左心室心肌做功参数的差异。结果:①CA1组、CA2组与对照组比较,左心室整体纵向应变(Global longitudinal strain,GLS)、整体做功指数(Global work index,GWI)、整体有效功(Global constructive work,GCW)、整体做功效率(Global work efficiency,GWE)降低(P<0.05),GLS达峰时间离散度(Peak strain dispersion,PSD)、整体无效功(Global wasted work,GWW)增高(P<0.05);CA2组与CA1组比较,GLS、GWE降低(P<0.05),GWW增高(P<0.05)。②CA1组、CA2组与对照组比较,基底段和心尖段纵向应变(Longitudinal strain,LS)、心肌做功指数(Myocardial work index,MWI)、心肌有效功(Myocardial constructive work,MCW)、心肌做功效率(Myocardial work efficiency,MWE)均降低(P<0.05),CA2组心尖段无效做功(Myocardial wasted work,MWW)较对照组及CA1组增加(P<0.05)。CA1组LS、MWI、MCW、MWE具有相对“心尖保留”模式,CA2组MWI、MCW、MWE无“心尖保留”模式。③GLS、GWW、心尖段MWW、MWW心尖/基底与LVEF呈负相关,GWE、心尖段MWE与LVEF呈正相关(P<0.05)。影响CA患者LVEF的主要因素为心尖段MWW及GLS(P<0.05)。结论:CA患者左心室整体及节段心肌做功减低,左心室心尖段MWW及GLS是影响CA患者LVEF的重要因素。左心室压力-应变环有望成为评价CA患者左心室心肌做功便捷、无创的影像学新方法。 展开更多
关键词 心脏病 淀粉样变性 心室功能 超声心动描记术
下载PDF
苦瓜总皂苷通过NRG-1/ErbB通路干预高血压心力衰竭大鼠心肌重构和纤维化
13
作者 高磊 李卫华 +1 位作者 陈忠 马智会 《心血管康复医学杂志》 CAS 2024年第2期210-216,共7页
目的:探究苦瓜总皂苷(MCS)通过神经调节蛋白-1(NRG-1)/红细胞白血病病毒癌基因同源物(ErbB)通路干预高血压心力衰竭(HF)大鼠心肌重构和纤维化的机制。方法:40只大鼠分为对照组、模型组、低剂量MCS组和高剂量MCS组(各10只)。通过高盐饮... 目的:探究苦瓜总皂苷(MCS)通过神经调节蛋白-1(NRG-1)/红细胞白血病病毒癌基因同源物(ErbB)通路干预高血压心力衰竭(HF)大鼠心肌重构和纤维化的机制。方法:40只大鼠分为对照组、模型组、低剂量MCS组和高剂量MCS组(各10只)。通过高盐饮食构建高血压HF模型。通过灌胃MCS进行干预(20 mg/kg和40 mg/kg,6周)。检测各组收缩压和心功能指标。HE染色、Masson染色和TUNEL染色分析MCS对高血压HF大鼠心肌损伤、纤维化和凋亡的影响。并比较各组心肌组织中NRG-1/ErbB通路mRNA和蛋白的表达量。结果:干预后,模型组的收缩压、LVEDP、Masson染色面积百分比(CVF)(7.94±0.82)%和凋亡指数(26.48±3.67)%显著高于对照组,而LVESP、±dp/dt_(max)、NRG-1和ErbB mRNA和蛋白水平显著低于对照组(P均=0.001)。低剂量MCS组和高剂量MCS组的收缩压、LVEDP、CVF[(5.26±0.51)%,(4.04±0.39)%]和凋亡指数[(17.35±2.01)%,(10.86±1.24)%]均显著低于模型组(P<0.05或<0.01),且高剂量MCS组的显著低于低剂量MCS组(P<0.05或<0.01)。低剂量MCS组和高剂量MCS组的LVESP、±dp/dt_(max)、NRG-1和ErbB mRNA和蛋白水平显著高于模型组(P<0.05或<0.01),且高剂量MCS组的显著高于低剂量MCS组(P<0.05或<0.01)。结论:MCS可能通过剂量依赖性地诱导NRG-1/ErbB通路抑制心肌细胞凋亡和纤维化,从而延缓高血压HF进展。 展开更多
关键词 心力衰竭 高血压 心室重构 纤维化
下载PDF
新型口服抗凝药对急性心肌梗死后心力衰竭合并室壁瘤附壁血栓消退影响的研究
14
作者 杨秀秀 关杨 +3 位作者 王悦 孙玉青 李峥 曾勇 《心肺血管病杂志》 CAS 2024年第4期331-335,342,共6页
目的:探讨新型口服抗凝药(novel oral anticoagulants,NOAC)用于治疗急性心肌梗死(acute myocardial infarction,AMI)后心力衰竭合并室壁瘤内附壁血栓的疗效。方法:入选2019年6月至2023年5月,首都医科大学附属北京安贞医院心内科门诊和... 目的:探讨新型口服抗凝药(novel oral anticoagulants,NOAC)用于治疗急性心肌梗死(acute myocardial infarction,AMI)后心力衰竭合并室壁瘤内附壁血栓的疗效。方法:入选2019年6月至2023年5月,首都医科大学附属北京安贞医院心内科门诊和病房患者中AMI后发生心力衰竭合并室壁瘤内附壁血栓患者118例,分别给予NOAC(NOAC组,65例)或维生素K受体拮抗剂(VKA组,53例)治疗,3个月后复查经胸超声心动图,如血栓尚未完全溶解,则在首次给药6个月后再次复查超声心动图。结果:NOAC组中,使用利伐沙班治疗者为46例,使用达比加群治疗者为19例,治疗3个月后血栓完全溶解率为70.8%。所有VKA组患者均使用华法林治疗,3个月后血栓完全溶解率为67.9%,与NOAC组相比差异无统计学意义(P>0.05)。治疗6个月后,NOAC组的血栓完全溶解率为90.8%,VKA组的血栓完全溶解率为84.9%,两组血栓溶解率对比差异无统计学意义(P>0.05)。结论:NOAC可考虑作为AMI后心力衰竭合并室壁瘤内附壁血栓消退的治疗药物,且无须监测INR,使用方便,安全性好。 展开更多
关键词 新型口服抗凝药 急性心肌梗死 心力衰竭 室壁瘤附壁血栓 维生素K受体拮抗剂
下载PDF
破格救心汤加减对心力衰竭合并室性心律失常患者生物标志物和近期不良心血管事件的影响
15
作者 刘红臻 朱粮 周波 《中国中医急症》 2024年第7期1208-1212,共5页
目的评价破格救心汤加减对心力衰竭合并室性心律失常患者生物标志物和近期不良心血管事件的影响。方法将88例心力衰竭合并室性心律失常患者随机分为对照组与观察组各44例。对照组进行抗心衰治疗,并口服美托洛尔缓释片和盐酸胺碘酮胶囊... 目的评价破格救心汤加减对心力衰竭合并室性心律失常患者生物标志物和近期不良心血管事件的影响。方法将88例心力衰竭合并室性心律失常患者随机分为对照组与观察组各44例。对照组进行抗心衰治疗,并口服美托洛尔缓释片和盐酸胺碘酮胶囊。观察组在对照组治疗的基础上口服破格救心汤加减治疗。比较治疗前后左室射血分数(LVEF)、每搏心输出量(SV)、左心室收缩末期内径(LVESD)、正常窦性心搏间期标准差(SDNN)、校正TP-Te间期(TP-Tec)每5分钟窦性心搏间期平均值的标准差(SDANN)、校正QT间期(QTc)和正常相邻R-R间期差值>50ms的百分比(Pnn50%);检测N末端B型利钠肽原(NT-proBNP)、生长分化因子15(GDF-15)可溶性肿瘤生成抑制因子-2(sST-2)和半乳糖凝集素-3(GAL-3)水平;记录近期不良心血管事件;进行治疗前后阳气亏虚血瘀证评分;比较心功能疗效和室性心律失常疗效。结果治疗后,观察组心功能疗效和室性心律失常疗效的总有效率均高于对照组(P<0.05);两组患者LVEF、SV升高,LVESD降低(P<0.05),均以观察组更明显(P<0.05);两组患者NT-proBNP、GAL-3、GDF-15和sST2水平下降(P<0.05),且观察组低于对照组(P<0.05);两组患者主要症状评分及阳气亏虚血瘀证总积分降低(P<0.05),且观察组低于对照组(P<0.05);两组患者QTc、TP-Tec减少,SDNN、SDANN和Pnn50%增加(P<0.05),且观察组改善明显(P<0.05)。观察组近期不良心血管事件累积发生率低于对照组(P<0.05)。结论破格救心汤加减方联合西医常规疗法治疗心力衰竭合并室性心律失常,能够抑制心室重构,提高心功能,减少不良心血管事件发生,临床疗效优于单纯的西医治疗。 展开更多
关键词 心力衰竭 室性心律失常 阳气亏虚血瘀证 破格救心汤 心室重构 不良心血管事件
下载PDF
益气养心方治疗冠心病室性心律失常的疗效及其对心肌缺血的血液流变学指标、CXCL9水平的影响
16
作者 黄卫清 杜婷婷 蔡洋 《检验医学与临床》 CAS 2024年第8期1046-1048,1053,共4页
目的观察益气养心方治疗冠心病室性心律失常的临床疗效及其对心肌缺血的血液流变学指标、CXC趋化因子配体9(CXCL9)水平的影响。方法选取2021年6月至2022年12月在该院治疗的70例冠心病室性心律失常患者作为研究对象,采用随机数字表法分... 目的观察益气养心方治疗冠心病室性心律失常的临床疗效及其对心肌缺血的血液流变学指标、CXC趋化因子配体9(CXCL9)水平的影响。方法选取2021年6月至2022年12月在该院治疗的70例冠心病室性心律失常患者作为研究对象,采用随机数字表法分为对照组和观察组,每组35例。两组患者均实施常规对症治疗,对照组在常规对症治疗的基础上给予酒石酸美托洛尔片治疗,观察组在对照组的基础上给予益气养心方治疗,两组患者均连续治疗4个月。观察两组临床疗效、血液流变学指标水平、血清CXCL9水平及不良反应情况。结果观察组治疗后总有效率高于对照组(P<0.05);两组治疗后全血低切黏度、全血高切黏度、血浆比黏度、纤维蛋白水平均低于治疗前,且观察组均低于对照组(P<0.05);两组治疗后血清CXCL9水平均低于治疗前,且观察组低于对照组(P<0.05);两组治疗过程中均未见严重不良反应,仅有极少数患者出现轻微恶心、呕吐症状。结论益气养心方治疗冠心病室性心律失常临床疗效较佳,可调低血清CXCL9水平,减轻心肌损伤,改善心肌的血液流变学指标,促进心律失常改善,且治疗安全性较高。 展开更多
关键词 益气养心方 冠心病 室性心律失常 心肌缺血 血液流变学 CXC趋化因子配体9 临床疗效
下载PDF
早期应用沙库巴曲缬沙坦对自发性高血压大鼠急性心肌梗死再灌注心功能及心室重构的影响及机制研究
17
作者 李淑娟 段莎莎 +3 位作者 阿拉腾宝力德 张培人 陈凤英 牛君义 《心肺血管病杂志》 CAS 2024年第9期998-1006,共9页
目的:研究早期应用沙库巴曲缬沙坦(Sacubattril/Valsartan,SAC/VAL)对自发性高血压大鼠急性心肌梗死(acute myocardial infarction,AMI)再灌注心脏重构及心功能的影响。方法:选取60只自发高血压大鼠。随机分为对照组(n=10)和实验组(n=50... 目的:研究早期应用沙库巴曲缬沙坦(Sacubattril/Valsartan,SAC/VAL)对自发性高血压大鼠急性心肌梗死(acute myocardial infarction,AMI)再灌注心脏重构及心功能的影响。方法:选取60只自发高血压大鼠。随机分为对照组(n=10)和实验组(n=50)。采取结扎冠状动脉的方法建立AMI大鼠再灌注模型;实验组大鼠随机分为三组,分别术后给予安慰剂(Model);预防性给予SAC/VAL与VAL;治疗性给予SAC/VAL与VAL。术后连续观察10周,以ELisa酶联免疫吸附法检测hs-TnT、NT-proBNP、TNF-α、IL-2、IL-6和IL-10等表达水平,以超声心动图测定大鼠LVEDD、LVESD、左心室舒张末容积(left Ventricular end-diastolic volume,LVEDV)、左心室收缩末容积(left ventricular end systolic volume,LVESV)、左心室短轴缩短率(fraction shortening,FS)及LVEF;10周后处死大鼠并以苏木素伊红(HE)染色,Masson染色,并计算胶原容积分数(collagen volume fraction CVF);用Western blot分析法测定心肌组织中p-NF-κB、p-IκB的蛋白水平。结果:(1)与Sham组比较,实验各组大鼠心肌细胞肥大、排列紊乱、纤维化明显,CVF显著升高(P <0.01);hs-TnT、NT-proBNP、TNF-α、IL-2、IL-6表达水平明显升高(P <0.01),IL-10表达水平明显下降(P <0.01);超声心动图测定心脏扩大且收缩功能显著受损(P <0.01)。(2)与Model组比较,用药各组梗死交界区心肌细胞结构相对完整,肌间隙变窄,CVF显著下降(P <0.01);hs-TnT、NTproBNP、TNF-α、IL-2、IL-6水平明显降低(P <0.01),IL-10表达水平明显升高(P <0.01);LVEDD、LVESD、LVEDV、LVESV明显下降(P <0.05),FS、EF值明显增加(P <0.01)。(3)在两组治疗方案中,SAC/VAL和VAL均可改善AMI后大鼠心功能,但SAC/VAL提供了更好的心功能保护,差异具有统计学意义(P <0.01)。(4) P-SAC/VAL组与T-SAC/VAL组比较,CVF减小更加明显,hs-TnT、NT-proBNP、TNF-α、IL-2、IL-6水平明显降低(P <0.01),IL-10表达水平明显升高(P<0.01),LVEDD、LVESD、LVEDV、LVESV明显下降(P <0.01),FS、EF值明显增加(P <0.01)。(5)与Model组比较相比,治疗组心肌组织中磷酸化核因子κB(phosphorylated nuclear factorkappa B,p-NF-κB)、磷酸化κB抑制蛋白(phosphorylated inhibitor of kappa B,p-IκB)表达下调(P <0.05)。结论:(1) SAC/VAL或VAL在AMI再灌注后均可有效改善心室重构、心功能;(2)与VAL相比,SAC/VAL在预防及治疗AMI诱导的心功能障碍方面效果更佳;(3) SAC/VAL早期预防性应用可更好地改善心功能。(4) SAC/VAL可能通过下调p-NF-κB、p-IκB蛋白表达发挥保护心功能的作用。此获益可能与SAC/VAL抑制心肌炎症反应,抑制细胞凋亡,减轻心肌纤维化,改善左心室重构相关。 展开更多
关键词 急性心肌梗死 心功能 沙库巴曲缬沙坦 心室重构 炎症
下载PDF
射血分数保留型心力衰竭患者心率变异性与左心室僵硬度的相关性
18
作者 梁仪 徐良洁 王春靓 《实用心电学杂志》 2024年第5期433-437,共5页
目的筛选反映射血分数保留型心力衰竭(heart failure with preserved ejection fraction,HFpEF)患者左心室僵硬度的敏感心率变异性(heart rate variability,HRV)指标,并评价其对HFpEF患者的预后评估价值。方法选取150例左心室射血分数(L... 目的筛选反映射血分数保留型心力衰竭(heart failure with preserved ejection fraction,HFpEF)患者左心室僵硬度的敏感心率变异性(heart rate variability,HRV)指标,并评价其对HFpEF患者的预后评估价值。方法选取150例左心室射血分数(LVEF)正常的患者,行24 h动态心电图及常规超声心动图检查。将入选患者分成正常对照组(68例)和HFpEF组(82例)。采用受试者工作特征曲线分析,筛选HRV指标中能反映HFpEF患者左心室僵硬度的敏感指标,并对主要终点事件进行随访。结果在HRV指标中,SDANN预测HFpEF的曲线下面积最大,达0.68(P<0.01),cut-off值90 ms。SDANN与左心室舒张期室壁应变呈负相关;SDANN越高,左心室僵硬度就越高。根据SDANN的cut-off值,HFpEF患者被分为高SDANN组(cut-off值≥90 ms,44例)和低SDANN组(cut-off值<90 ms,38例)。低SDANN组左心室僵硬度较低。生存曲线分析显示,高SDANN组的主要不良心脏事件发生率和全因死亡率较低SDANN组显著升高(P<0.05)。结论SDANN可作为HFpEF患者临床诊断及预后评估的敏感指标。 展开更多
关键词 心率变异性 左心室僵硬度 射血分数保留型心力衰竭 动态心电图
下载PDF
国产第三代磁悬浮左心室辅助装置植入同期行二尖瓣成形术的初步评价
19
作者 王志华 段晓夏 +5 位作者 赵泽原 胡俊龙 陈志高 李建朝 王保才 程兆云 《中国循环杂志》 CSCD 北大核心 2024年第3期242-248,共7页
目的:探讨国产第三代磁悬浮Corheart 6左心室辅助装置(LVAD)植入同期行二尖瓣成形术(MVP)的安全性及有效性。方法:回顾性分析2021年10月至2023年3月于郑州大学华中阜外医院接受Corheart 6 LVAD植入同期行MVP的终末期心力衰竭患者13例。... 目的:探讨国产第三代磁悬浮Corheart 6左心室辅助装置(LVAD)植入同期行二尖瓣成形术(MVP)的安全性及有效性。方法:回顾性分析2021年10月至2023年3月于郑州大学华中阜外医院接受Corheart 6 LVAD植入同期行MVP的终末期心力衰竭患者13例。收集院内、随访时的死亡及并发症事件,观察患者的心肌损伤、肾功能、血液动力学和超声心动图指标变化。结果:13例患者围术期无死亡、无MVP相关并发症。平均随访(14.2±5.6)个月期间,11例(84.6%)完成随访,2例分别因新型冠状病毒肺炎、心脏骤停死亡,无中重度二尖瓣反流复发。与术前相比,患者术后24 h、72 h心输出量升高,中心静脉压、肺动脉收缩压(PASP)、平均肺动脉压(PAMP)降低,术后1周高敏心肌肌钙蛋白T升高,估算肾小球滤过率降低,差异均有统计学意义(P均<0.010)。超声心动图检查显示,与术前相比,术后1、6个月左心室射血分数虽升高,但差异无统计学意义(P均>0.017),而左心室舒张末期内径、PASP、PAMP降低差异均有统计学意义(P均<0.010)。结论:国产第三代磁悬浮Corheart 6 LVAD植入同期行MVP安全、可行,术后近中期无中重度二尖瓣反流复发,肺动脉压显著降低,血液动力学显著改善。 展开更多
关键词 心力衰竭 二尖瓣反流 左心室辅助装置 二尖瓣成形
下载PDF
左西孟旦联合环磷腺苷对老年急性左心衰竭患者的疗效
20
作者 刘红岗 李晶 《国际医药卫生导报》 2024年第8期1264-1268,共5页
目的探讨左西孟旦联合环磷腺苷对老年急性左心衰竭患者心室重构及血清肌钙蛋白I(TnI)和瞬时受体电位通道1(TRPC1)水平的影响。方法选取2022年6月到2023年11月在韩城市人民医院诊治的老年急性左心衰竭患者96例,采用信封法分为观察组和对... 目的探讨左西孟旦联合环磷腺苷对老年急性左心衰竭患者心室重构及血清肌钙蛋白I(TnI)和瞬时受体电位通道1(TRPC1)水平的影响。方法选取2022年6月到2023年11月在韩城市人民医院诊治的老年急性左心衰竭患者96例,采用信封法分为观察组和对照组,每组48例,进行前瞻性研究。观察组男25例,女23例;年龄(76.97±5.23)岁;体质量指数(25.35±2.79)kg/m^(2);心功能分级:Ⅲ级30例,Ⅳ级18例。对照组男26例,女22例;年龄(77.41±5.16)岁;体质量指数(25.14±2.62)kg/m^(2);心功能分级:Ⅲ级31例,Ⅳ级17例。两组均给予利尿、强心、扩张血管等常规干预;对照组给予环磷腺苷治疗,观察组给予左西孟旦联合环磷腺苷治疗,两组均为静脉滴注给药,治疗周期均为7 d。比较两组临床疗效、心室重构指标[室间隔厚度(IVST)、左室后壁厚度(LVPWT)、左心室质量指数(LVMI)]、心脏储备功能指标[左心室射血分数(LVEF)、左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)]、血清TnI和TRPC1水平及不良反应发生情况。采用独立样本t检验、配对样本t检验和χ^(2)检验。结果治疗后,观察组的总有效率[91.67%(44/48)]高于对照组[75.00%(36/48)](P<0.05)。治疗后,观察组心室重构指标均优于对照组[IVST:(7.45±0.82)mm比(9.04±1.11)mm、LVPWT:(8.09±0.84)mm比(8.89±1.07)mm、LVMI:(112.67±15.12)g/m^(2)比(120.21±16.83)g/m^(2)](均P<0.05)。治疗后,观察组患者的LVEF高于对照组[(56.32±6.01)%比(51.78±5.90)%],LVESD、LVEDD均低于对照组[(50.27±5.98)mm比(59.46±6.24)mm、(53.92±7.47)mm比(62.85±7.22)mm](均P<0.05)。治疗后,观察组血清TnI和TRPC1水平均低于对照组[(0.34±0.06)µg/L比(0.46±5.90)µg/L、(8.25±1.62)ng/L比(13.27±2.07)ng/L](均P<0.05)。观察组在治疗期间总不良反应发生率[16.67%(8/48)]与对照组[14.58%(7/48)]比较,差异无统计学意义(P>0.05)。结论左西孟旦联合环磷腺苷能有效改善老年急性左心衰竭患者的心室重构,提高心脏功能,降低血清TnI和TRPC1水平,有利于左心衰竭患者的康复治疗。 展开更多
关键词 左西孟旦 环磷腺苷 老年 急性左心衰竭 心室重构 肌钙蛋白I 瞬时受体电位通道1
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部